Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 286-290

  Iwatsubo, Haruhiko ^b   Nagano, Masahiro ^a   Sakai, Tomoko ^b   Kumamoto, Kunihiko ^b   Morita, Ryuhei ^b   Higaki, Jitsuo ^b   Ogihara, Toshio ^b   Hata, Takeshi ^b  

^a Department of Anesthesiology   (Japan)

^b NONE

Author keywords

amlodipine; antihypertensive drug; atherosclerosis; hyperemia; nitroglycerin; plethysmography; temocapril

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; TEMOCAPRIL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; STRAIN GAUGE TRANSDUCER; SUBLINGUAL DRUG ADMINISTRATION; VASODILATATION;

EID: 0031035842     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.286     Document Type: Article

References (46)

1. Vanhoutte PM. Endothelium and control of vascular function. Hypertension. 1989;13:658-667.
2. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation. 1992;85:1927-1938.
3. Ross R. The pathogenesis of atherosclerosis. N Engl J Med. 1986; 314:488-500.
4. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
5. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
6. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for the release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
7. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992; 10:1025-1031.
8. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
9. Iiyama K, Nagano M, Yo Y, Nagano N, Kamide K, Higaki J, Mikami H, Ogihara T. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J. 1996;132:779-782.
10. Iwatsubo H, Nagano M, Sakai T, Morita R, Kumamoto K, Higaki J, Ogihara T, Hata T. Impaired endothelium-dependent vasodilation in essential hypertensive patients with left ventricular hypertrophy. J Hypertens. 1996;14(suppl 1):S47. Abstract.
11. Clozel M, Kuhn H, Hefti F. Effect of angiotensin-converting enzyme inhibitor and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990;16:532-540.
12. Goldschmidt JE, Tallarida RJ. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1991;257:1136-1145.
13. Novosel D, Lang MG, Noll G, Luscher TF. Endothelial dysfunction in aorta of the spontaneously hypertensive, stroke-prone rat: effects of therapy with verapamil and trandolapril alone and in combination. J Cardiovasc Pharmacol. 1994;24:979-985.
14. Young R-H, Ding Y-A, Lee Y-M, Yen M-H. Cilazapril reverses endothelium-dependent vasodilator response to acetylcholine in mesenteric artery from spontaneously hypertensive rats. Am J Hypertens. 1995;8:928-933.
15. Shultz PJ, Raij L. Effect of antihypertensive agents on endothelium-dependent and endothelium-independent relaxation. Br J Clin Pharmacol. 1989;28:1515-1575.
16. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshita A, Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension. 1992;20: 175-180.
17. Schiffrin EL, Deng L-Y. Comparison of effects of angiotensin I-converting enzyme inhibition and β-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension. 1995; 25:699-703.
18. Creager MA, Roddy M-A. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994;24: 499-505.
19. Kiowski W, Linder L, Nuesch R, Martina B. Effects of cilazapril on vascular structure and function in essential hypertension. Hypertension. 1996;27:371-376.
20. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of artherosclerosis. Lancet. 1992;340:1111-1115.
21. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension. 1986;8:37-44.
22. Anderson EA, Mark AL. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation. 1989;79:93-100.
23. Hokanson DE, Sumner DS, Strandness DEJ. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng. 1975;22:25-29.
24. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21:1145-1151.
25. Laurent S, Lacolley P, Brunel P, Laloux B, Pannier B, Safar M. Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol. 1990;258:H1004-H1011.
26. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM, Phil D. Preserved endothelium-dependent vasodilation in patients with essential hypertension. N Engl J Med. 1994;330:1036-1040.
27. Luscher TF. Heterogeneity of endothelial dysfunction in hypertension. Eur Heart J. 1992;13(suppl D):50-55.
28. Mombouli JV, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res. 1992;71:137-144.
29. Vanhoutte PM, Boulanger CM, Mombouli JV. Endothelium-derived relaxing factors and converting enzyme inhibition. Am J Cardiol. 1995;76:3E-12E.
30. Nagano M, Higaki J, Nakamura F, Higashimori K, Nagano N, Mikami H, Ogihara T. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension. 1992; 19:708-712.
31. Morishita R, Higaki J, Miyazaki M, Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension. 1992;19(suppl II):II-62-II-67.
32. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Buhler FR. Stimulation of endothelin mRNA and secretion in the rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1990;1: 649-659.
33. Lin L, Mistry M, Stier CTJ, Nasjletti A. Role of prostanoids in renin-dependent and renin-independent hypertension. Hypertension. 1991; 17:517-525.
34. Griendling K, Ollerenshaw JD, Minieri CA, Alexander RW. Angiotensin II stimulates NADH and NADPH activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
35. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman B, Griendling K, Harrison D. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
36. Long CJ, Stone TW. The release of endothelium-derived relaxant factor is calcium dependent. Blood Vessels. 1985;22:205-208.
37. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682-685.
38. Rubanyi G, Schwartz A, Vanhoutte PM. The calcium-channel agonists Bay K 8644 and (+) 202,791 stimulate the release of endothelial relaxing factor from canine femoral arteries. Eur J Pharmacol. 1985;117:143-144.
39. Busse R, Lückhoff A, Winter I, Mülsch A, Pohl U. Fendiline and calmidazolium enhance the release of endothelium-derived relaxant factor and prostacyclin from cultured endothelial cells. Arch Pharm (Winheim). 1988;337:79-84.
40. Mügge A, Peterson J, Harrison DG. Release of nitrogen oxides from cultured bovine aortic endothelial cells is not impaired by calcium channel antagonists. Circulation. 1991;83:1404-1409.
41. Carlsson I, Sollevi A, Wennmalm Å. The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperaemia. J Physiol. 1987;389:147-161.
42. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemic in human forearm vessels. Circulation. 1994;90:2285-2290.
43. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens. 1992;5:95-110.
44. Group TCTS. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
45. Maschio G, Alberti D, Janin G, Locatelli F, Mann J, Motolese M, Ponticelli C, Ritz E, Zucchelli P, and the Angiotensin-Converting Enzyme Inhibition in Progressive Renal Insufficiency Study Group. Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med. 1996; 334:939-945.
46. Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Lüscher TF, Klibaner MI, Haber HE, Uprichard ACG, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing Endothelial Dysfunction) study. Circulation. 1996;94:258-265.